Medical Decision Making in Multiple System Atrophy

Sponsor
Medical University Innsbruck
Study ID
NCT06072105
Status
Recruiting
Apply to this trial

Conditions

  • Multiple System Atrophy

Eligibility Criteria

Sex
ALL
Age
30 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Telemedicine visits — OTHER
    Monthly telemedicine neurological, psychological and neurorehabilitation (physio-, occupational and speech therapy) consultations
  • Multidisciplinary, personalized symptomatic treatment — OTHER
    Multidisciplinary, personalized symptomatic treatment plus mobile palliative care interventions (if wished and needed)

Study Details

The goal of this clinical study is to evaluate the effects of a personalized symptomatic treatment plan integrated with monthly telemedicine and mobile palliative care interventions on a population of individuals diagnosed with Multiple System Atrophy (MSA) and their informal caregivers. The aim is to improve the quality of life of MSA patients and their caregivers, as well as provide them with better support during the disease progression. After a baseline visit, all 46 patients will receive a personalized therapeutic plan (including medical treatment, physiotherapy, logotherapy and occupational therapy excercises and psychological support) and contact with social workers and a palliative care team. They willl then be re-evaluated at 6-,12-, 18- month visits. Semi-structured online interviews at baseline and 12 month visit will collect patients' individual healthcare preferences, which will be taken into account in the preparation of the individual therapeutic plan. Twenty-three patients will be randomized to receive monthly telemedicine visits. Assessment of patients´satisfaction with the therapeutic plan, with the palliative interventions (when they occurred) and the telemedicine visits will be carried over the 18 month period. Forty-six informal caregivers will be invited to participate with semi-structured online interviews and assessment of their QoL and caregivers' burden.

Key Dates

First listed
Oct 10, 2023
Start date
Oct 1, 2023
Status verified
Feb 2025
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
92 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: Group 1
    Personalized best medical care.
  • Experimental: Group 2
    Personalized best medical care PLUS telemedicine

Primary Outcome Measure

Change in the EQ-5D-5L score [ Time Frame: Baseline to 18-months ]

Central Contacts

Related Studies